INFUSYSTEM HOLDINGS, INC APIC, Share-based Payment Arrangement, Increase for Cost Recognition
INFUSYSTEM HOLDINGS, INC (INFU) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $1.24 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Shareholders' Equity › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-04
- INFUSYSTEM HOLDINGS, INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $1.24M, a 87.90% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $1.23M, a 11.28% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $1.27M, a 7.43% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $1.32M, a 8.27% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $4.36M, a 2.17% decline from fiscal 2024.
- INFUSYSTEM HOLDINGS, INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $4.46M, a 9.47% increase from fiscal 2023.
- INFUSYSTEM HOLDINGS, INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $4.07M, a 6.51% increase from fiscal 2022.
- INFUSYSTEM HOLDINGS, INC apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $3.83M, a 40.27% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.24M 10-Q · filed 2026-08-04 | $2.48M 10-Q · filed 2026-08-04 | $3.75M derived: sum of 3 quarters · filed 2026-08-04 | $5.07M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | $1.23M 10-Q · filed 2026-05-08 | $2.50M derived: sum of 2 quarters · filed 2026-05-08 | $3.83M derived: sum of 3 quarters · filed 2026-05-08 | $4.49M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.59M derived: sum of 2 quarters · filed 2026-02-27 | $3.25M derived: sum of 3 quarters · filed 2026-08-04 | $4.36M 10-K · filed 2026-02-27 | |
| 2025-09-30 | $1.32M 10-Q · filed 2025-11-04 | $1.98M derived: sum of 2 quarters · filed 2026-08-04 | $3.09M 10-Q · filed 2025-11-04 | $4.28M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-06-30 | $661.00K 10-Q · filed 2026-08-04 | $1.77M 10-Q · filed 2026-08-04 | $2.95M derived: sum of 3 quarters · filed 2026-08-04 | $4.17M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-03-31 | $1.11M 10-Q · filed 2026-05-08 | $2.29M derived: sum of 2 quarters · filed 2026-05-08 | $3.51M derived: sum of 3 quarters · filed 2026-05-08 | $4.51M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.40M derived: sum of 2 quarters · filed 2026-02-27 | $3.40M derived: sum of 3 quarters · filed 2026-02-27 | $4.46M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $1.22M 10-Q · filed 2025-11-04 | $2.22M derived: sum of 2 quarters · filed 2025-11-04 | $3.28M 10-Q · filed 2025-11-04 | $4.55M derived: sum of 4 quarters · filed 2025-11-04 | |
| 2024-06-30 | $998.00K 10-Q · filed 2025-08-05 | $2.06M 10-Q · filed 2025-08-05 | $3.33M derived: sum of 3 quarters · filed 2025-08-05 | $4.39M derived: sum of 4 quarters · filed 2025-08-05 | |
| 2024-03-31 | $1.06M 10-Q · filed 2025-05-08 | $2.33M derived: sum of 2 quarters · filed 2025-05-08 | $3.40M derived: sum of 3 quarters · filed 2025-05-08 | $4.41M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $2.34M derived: sum of 2 quarters · filed 2025-03-11 | $3.35M derived: sum of 3 quarters · filed 2025-03-11 | $4.07M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $1.06M 10-Q · filed 2024-11-08 | $2.08M derived: sum of 2 quarters · filed 2024-11-08 | $2.80M 10-Q · filed 2024-11-08 | $3.39M derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | $1.02M 10-Q · filed 2024-08-09 | $1.74M 10-Q · filed 2024-08-09 | $2.33M derived: sum of 3 quarters · filed 2024-08-09 | $3.39M derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | $720.00K 10-Q · filed 2024-05-09 | $1.31M derived: sum of 2 quarters · filed 2024-05-09 | $2.38M derived: sum of 3 quarters · filed 2024-05-09 | $3.50M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $589.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $1.66M derived: sum of 2 quarters · filed 2024-04-10 | $2.78M derived: sum of 3 quarters · filed 2024-04-10 | $3.83M 10-K · filed 2024-04-10 | |
| 2022-09-30 | $1.07M 10-Q · filed 2023-11-09 | $2.19M derived: sum of 2 quarters · filed 2023-11-09 | $3.24M 10-Q · filed 2023-11-09 | $4.68M derived: sum of 4 quarters · filed 2024-04-10 | |
| 2022-06-30 | $1.12M 10-Q · filed 2023-08-09 | $2.17M 10-Q · filed 2023-08-09 | $3.61M derived: sum of 3 quarters · filed 2024-04-10 | $5.57M derived: sum of 4 quarters · filed 2024-04-10 | |
| 2022-03-31 | $1.05M 10-Q · filed 2023-05-09 | $2.49M derived: sum of 2 quarters · filed 2024-04-10 | $4.44M derived: sum of 3 quarters · filed 2024-04-10 | $5.82M derived: sum of 4 quarters · filed 2024-04-10 | |
| 2021-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $3.40M derived: sum of 2 quarters · filed 2024-04-10 | $4.77M derived: sum of 3 quarters · filed 2024-04-10 | $6.40M 10-K · filed 2024-04-10 | |
| 2021-09-30 | $1.96M 10-Q · filed 2022-11-08 | $3.33M derived: sum of 2 quarters · filed 2022-11-08 | $4.96M 10-Q · filed 2022-11-08 | $6.35M derived: sum of 4 quarters · filed 2023-03-16 | |
| 2021-06-30 | $1.37M 10-Q · filed 2022-08-04 | $254.00K 10-Q · filed 2021-08-12 | $3.01M 10-Q · filed 2022-08-04 | $4.39M derived: sum of 3 quarters · filed 2023-03-16 | $5.05M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $1.64M 10-Q · filed 2022-05-05 | $3.02M derived: sum of 2 quarters · filed 2023-03-16 | $3.68M derived: sum of 3 quarters · filed 2023-03-16 | $4.04M derived: sum of 4 quarters · filed 2023-03-16 | |
| 2020-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $2.05M derived: sum of 2 quarters · filed 2023-03-16 | $2.40M derived: sum of 3 quarters · filed 2023-03-16 | $2.61M 10-K · filed 2023-03-16 | |
| 2020-09-30 | $659.00K 10-Q · filed 2021-11-15 | $1.02M derived: sum of 2 quarters · filed 2021-11-15 | $1.22M 10-Q · filed 2021-11-15 | $1.45M derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-06-30 | $357.00K 10-Q · filed 2021-08-12 | $563.00K 10-Q · filed 2021-08-12 | $790.00K derived: sum of 3 quarters · filed 2022-03-15 | $1.03M derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-03-31 | $206.00K 10-Q · filed 2021-05-10 | $433.00K derived: sum of 2 quarters · filed 2022-03-15 | $673.00K derived: sum of 3 quarters · filed 2022-03-15 | $957.00K derived: sum of 4 quarters · filed 2022-03-15 | |
| 2019-12-31 | $227.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $467.00K derived: sum of 2 quarters · filed 2022-03-15 | $751.00K derived: sum of 3 quarters · filed 2022-03-15 | $997.00K 10-K · filed 2022-03-15 | |
| 2019-09-30 | $240.00K 10-Q · filed 2020-11-13 | $524.00K derived: sum of 2 quarters · filed 2020-11-13 | $770.00K 10-Q · filed 2020-11-13 | $1.05M derived: sum of 4 quarters · filed 2020-11-13 | |
| 2019-06-30 | $284.00K 10-Q · filed 2020-08-14 | $530.00K 10-Q · filed 2020-08-14 | $808.00K derived: sum of 3 quarters · filed 2020-08-14 | $1.26M derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | $246.00K 10-Q · filed 2020-05-15 | $524.00K derived: sum of 2 quarters · filed 2020-05-15 | $977.00K derived: sum of 3 quarters · filed 2020-05-15 | $1.09M derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | $278.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $731.00K derived: sum of 2 quarters · filed 2020-03-30 | $845.00K derived: sum of 3 quarters · filed 2020-03-30 | $957.00K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $453.00K 10-Q · filed 2019-11-14 | $567.00K derived: sum of 2 quarters · filed 2019-11-14 | $679.00K 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | $114.00K 10-Q · filed 2019-08-14 | $226.00K 10-Q · filed 2019-08-14 | |||
| 2018-03-31 | $112.00K 10-Q · filed 2019-05-15 | ||||
| 2017-12-31 | $682.00K 10-K · filed 2019-03-22 | ||||
| 2016-12-31 | $462.00K 10-K · filed 2018-03-19 | ||||
| 2015-12-31 | $996.00K 10-K · filed 2017-03-22 | ||||
| 2014-12-31 | $576.00K 10-K/A · filed 2016-12-12 | ||||
| 2013-12-31 | $1.12M 10-K · filed 2015-03-09 | ||||
| 2012-12-31 | $1.33M 10-K · filed 2014-03-11 | ||||
| 2011-12-31 | $970.00K 10-K · filed 2013-03-28 | ||||
| 2010-12-31 | $3.86M 10-K · filed 2012-03-16 | ||||
| 2009-12-31 | $753.00K 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |